Centre for Prevention of Stroke and Dementia
We increase understanding of the causes of cerebrovascular disease and improve the prevention of stroke and vascular dementia in routine clinical practice.
The Centre for the Prevention of Stroke and Dementia was founded as the Stroke Prevention Research Unit in 2000 by Professor Peter Rothwell with initial funding from the MRC and the Stroke Association.
Now comprising about 30 researchers and support staff, the centre is regarded as one of the most productive stroke research groups in the world. In summer 2019, it moves into a purpose-built new facility on the John Radcliffe Hospital site.
13 September 2019
The charity has provided £126K of funding for one 3-year clinical research fellowship starting in January 2020.
2 May 2019
Risk of dementia after stroke is a major concern for patients and carers. Reliable data on risk of dementia, particularly after TIA or minor stroke, are scarce.
26 September 2018
Tuesday 25 September saw the 'topping out' ceremony, with completion on course for next summer
27 July 2018
About one billion people worldwide take regular aspirin, usually to prevent heart attacks or strokes. But a new study suggests a more tailored strategy is required.
3 July 2018
Professor Peter Rothwell says more must be done to raise awareness of the need to take rapid action after a mini-stroke in order to reduce the number of major strokes.
Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.
Pendlebury ST. et al, (2019), Lancet Neurol, 18, 248 - 258
Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis
Mazzucco S. et al, (2018), The Lancet Neurology, 17, 609 - 617
Medical Attention Seeking After Transient Ischemic Attack and Minor Stroke Before and After the UK Face, Arm, Speech, Time (FAST) Public Education Campaign
Wolters FJ. et al, (2018), JAMA Neurology
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Rothwell PM. et al, (2018), The Lancet, 392, 387 - 399
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study
Li L. et al, (2017), The Lancet, 390, 490 - 499